Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Hematology  |  Devices

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Hemodialysis Clinical Trials

A listing of Hemodialysis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (28) clinical trials

Cost-effectiveness of Urgent-start Therapies Hemodialysis and Peritoneal Dialysis

Despite evidence of worse outcomes, initiation of renal replacement therapy by unplanned modalities in chronic kidney disease (CKD) patients is the reality in the practice for both hemodialysis and peritoneal dialysis. Unplanned therapy peritoneal dialysis (PD) is the initiation of the modality in less than 48 hours after implantation of ...

Phase N/A

Wise Practice of Chinese Hemodialysis (WISHES)

The investigators are registering all end stage renal disease (ESRD) patients receiving hemodialysis (HD) treatment, and developing a HD database in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education), clinical characteristics (including systolic blood pressure, diastolic blood pressure, primary cause of ESRD, and lab ...

Phase N/A

Effects of Postdilution Online Hemodiafiltration AcEtate-free Citrate dialySis Fluid on Inflammation Markers in TUscan Prevalent Hemodialysis patientS

The primary objective of this study was to evaluate if a hemodiafiltration with concentrated citrate (Cit-HDF) in 3 months can reduce the inflammation markers, evaluated by a Predialytic value of Beta2-microglobulin (B2m), CRP and IL6 compared to traditional concentrated acetic acid (Ac-HDF). The secondary objectives of this study are to ...

Phase N/A

the Study on Prognostic for Hemodialysis Patients

It is common that the abnormalities in parathyroid hormone (PTH) levels appear in patients with moderate and advanced chronic kidney diseases (CKD). CKD-mineral and bone disorder (CKD-MBD), manifested by the serum calcium (Ca), phosphorus (P), and parathyroid hormone (PTH) levels, and other abnormalities such as vitamin D metabolism and bone ...

Phase N/A

Integrative HD Vascular Access Assessment

Background The effectiveness of hemodialysis (HD) depends on HD vascular access (HVA). Individualized prevention based on TCM constitutions can help persons to restore balance and prevent disease. To prevent the negative development of HVA and maintain HVA patency, development of an integrative model of HVA should be an important issue ...

Phase N/A

Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis

Data collection including medical history, operative procedure data, and follow-up data every six months while using the HeRO Graft for dialysis, including: Post-operative complications for HeRO Graft implantation Length of time between insertion and use of HeRO Graft Incidence of thrombosis Hospitalizations Incidence of infections and other adverse event occurrence ...

Phase N/A

Sleep Disturbance in Patients With End-Stage Renal Disease

Patients will not selected based on presence/absence of sleep disturbance. Patients will be prioritized for recruitment if they were active on the transplant waitlist or a change in RRT modality is planned. Patients will be selected for inclusion if they were >16 years old, competent to independently undertake the informed ...

Phase N/A

Study of the Prevalence of Fabry Disease in French Dialysis Patients

Fabry Disease (FD) is a rare genetic lysosomal storage disease including an X-linked mutation and characterized by an alpha-galactosidase A (GLA) deficiency. It causes globotriaosylceramide (GB3) accumulation within blood vessels, tissues and organs. This accumulation leads to multisystemic deficiency, such as progressive kidney insufficiency. Due to its low prevalence and ...

Phase N/A

Hypoxemia in Maintenance Hemodialysis Patients

Following the initial recruitment, all individuals who are willing to participate and sign the informed consent document will be provided with a medical history form to complete. In addition, the investigators will ask participants to sign a HIPAA authorization form in order to look into their medical records for monthly ...

Phase N/A

Prognostic Value of Central and BracHial Ambulatory Blood Pressure Monitoring in ERSD Patients Treated With HeMOdialysis

The protocol of this study was approved by the local ethical review board. The including criteria: 1) ESRD treated with hemodialysis for more than 3 months prior to study enrollment; 2) agree to participate the study and sign informed written consent; 3) available for long-term follow-up. The excluding criteria: 1)chronic ...

Phase N/A